{{Rsnum
|rsid=7190458
|Chromosome=16
|Orientation=plus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=BCAR1
|position=75229763
|Gene_s=BCAR1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.9 | 9.7 | 89.4
| HCB | 0.0 | 4.4 | 95.6
| JPT | 0.0 | 2.7 | 97.3
| YRI | 10.3 | 43.2 | 46.6
| ASW | 1.8 | 40.4 | 57.9
| CHB | 0.0 | 4.4 | 95.6
| CHD | 0.0 | 5.5 | 94.5
| GIH | 0.0 | 0.0 | 0.0
| LWK | 7.3 | 31.8 | 60.9
| MEX | 0.0 | 13.8 | 86.2
| MKK | 4.5 | 31.4 | 64.1
| TSI | 0.0 | 4.9 | 95.1
| HapMapRevision=28
}}A 2014 study "Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer" of 7,683 European cases and 14,397 controls found the minor allele [[rs7190458]](A) in [[BCAR1]] (breast cancer anti-estrogen resistance 1) conferring risk of statistically genome-wide significance (per-allele odds ratio (OR) = 1.46, 95% confidence interval (CI) 1.30-1.65, P = 1.1E-10) for [[Pancreatic cancer]].

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}